MedDataX Logo

Clinical Experimental Study to Investigate Specific Features of ClampArt®

NCT ID: NCT01906970

Last Updated: 2024-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-19

Study Completion Date

2024-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A single centre, clinical experimental study. Every subject will undergo clamp experiments, where a clamp device (ClampArt®) measures and controls the blood glucose concentration after administration of marketed insulin products.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device

NCT01060917

Diabetes Mellitus
COMPLETED PHASE1/PHASE2

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use

NCT04033042

Diabetes Mellitus
COMPLETED NA

Continuous GlucoseMonitor for Measurement of Blood Glucose Level

NCT01580176

Other Surgical Procedures
COMPLETED NA

A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes

NCT01730885

Diabetes Mellitus
COMPLETED PHASE4

Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems

NCT01751932

Diabetes Mellitus
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ClampArt

ClampArt

Group Type EXPERIMENTAL

ClampArt

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ClampArt

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy, TD1, TD2

Exclusion Criteria

* Participation in a Trial within the last weeks
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tim Heise, MD

Role: PRINCIPAL_INVESTIGATOR

Profil Institut für Stoffwechselforschung GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Profil Institut für Stoffwechselforschung GmbH

Neuss, North Rhine-Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ClampArt-ES2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes
NCT01234727 COMPLETED
Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method
NCT01058577 COMPLETED PHASE1
Validation of a 13C Glucose Breath Test Compared With the Euglycaemic Clamp Test
NCT04623320 UNKNOWN
Study of a Non-invasive Glucose Measuring Device
NCT05851469 COMPLETED NA
Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes
NCT01460459 UNKNOWN NA
Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus
NCT01729546 COMPLETED NA
Evaluation of the Accuracy of an Implanted Glucose Sensor
NCT02647905 COMPLETED NA
Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients
NCT01588106 COMPLETED
Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus
NCT02439177 TERMINATED NA
System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System
NCT02710617 COMPLETED NA
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
NCT00806520 COMPLETED
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting
NCT01268488 COMPLETED NA
The Blood Glucose Control in Patients With Type 2 Diabetes Treated With Glargine
NCT03566472 UNKNOWN
Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food
NCT00818077 COMPLETED
System Accuracy of BGM GL22
NCT06146933 COMPLETED NA
A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes
NCT01780272 COMPLETED PHASE1
Measurement Algorithm Control and Optimization With Subsequent Performance Evaluation of Sanmina Non-invasive Biosensors During a Standardized Meal Test in Patients With Diabetes Mellitus Type 1 and Type 2
NCT04379427 COMPLETED NA
Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
NCT04147273 COMPLETED NA
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
NCT00465881 COMPLETED
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial
NCT01328717 COMPLETED NA
Performance Study Using the OptiScanner on Healthy Diabetics
NCT01135771 COMPLETED PHASE1
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
NCT01237301 COMPLETED NA
The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA
NCT01787903 COMPLETED NA
Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics
NCT01645696 COMPLETED NA
Comparative Study Between Two Models of a Non-invasive Glucose Monitoring Device
NCT03530644 COMPLETED NA